Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis B

US11845752B2 · kind B2 · utility

Assignee

• Aligos Therapeutics, Inc. · US

Inventors

• Sandrine Marie Helene Vendeville · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, BE
• Yannick Debing · Bilzen, BE
• Antitsa Dimitrova Stoycheva · Rue de l'Église, US
• Pierre Jean-Marie Bernard Raboisson · Sligo, IE

Key dates

• Filing date: Oct 13, 2021
• Grant date: Dec 19, 2023
• Expiry date: Oct 13, 2041

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D519/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.